Healthcare · Vaccine antigens production

Vaccine antigens production in Canada in 2026

In 2026, Canada did not produce vaccine antigens on an industrial scale — the figure stood at 60 million doses million doses, ranking 7th out of 197 countries. The country traditionally imports most vaccines, focusing instead on biotech research and novel platform development. Pilot-scale production exists at universities in Ottawa and Montreal, but mass antigen manufacturing is not established.

Data for 2026 · unit: million doses
Position

Canada world ranking

#7 / 197

Country position on the scale from last to first place for this indicator.

CA
#7
#197#1
Trend

Change over time

Change in indicator over the available period.

1
1950
20
1990
40
2000
50
2010
100
2020
60
2025
60
2026

Values — million doses

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Vaccine antigens production in Canada — how much?
Based on 2026 data — 60 million doses. This is rank #7 out of 197 countries.
What is Canada's rank by Vaccine antigens production?
Canada ranks #7 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Canada?
Over the available period the indicator changed from 1 to 60 million doses.